Directed sibling donor cord blood donation in the Chilean Public Health System

Cristián Sotomayor1, Lucía Salas1, José Lattus2

  • 1Unidad de trasplante de Médula Ósea, Hospital Dr. Luís calvo Mackenna, Santiago, Chile.

Insights

Chile's National Childhood Cancer Program (PINDA) collected cord blood units for hematopoietic stem cell transplantation (HSCT). The program enabled HSCT for four high-risk leukemia patients, demonstrating a model for a national cord blood bank.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • Pediatric Oncology

Background:

  • Cord blood (CB) is a recognized source for Hematopoietic Stem Cell Transplantation (HSCT).
  • Less than 10% of global CB HSCTs utilize matched sibling donors.
  • Chile's National Childhood Cancer Program (PINDA) initiated a directed donation program for CB HSCT in 2004.

Purpose of the Study:

  • To assess the quantity and characteristics of CB units collected by the PINDA program.
  • To evaluate the clinical characteristics and outcomes of patients receiving HSCT from these CB units.
  • To analyze the follow-up data of patients undergoing HSCT within the program.

Main Methods:

  • An observational, descriptive, and retrospective study design.
  • Collection and storage of 60 CB units between January 2004 and October 2018.
  • Analysis of patient clinical data and transplantation outcomes.

Main Results:

  • 55 CB units were successfully collected and stored, with median volumes and cell counts detailed.
  • Four high-risk leukemia patients received HSCT.
  • While complications and one death occurred, surviving patients achieved a 100% Karnofsky/Lansky score after an 8-year median follow-up.

Conclusions:

  • The PINDA program provided essential HSCT access for four patients lacking other donor options.
  • This directed donation initiative serves as a potential model for establishing a public cord blood bank in Chile.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
713
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.0K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
216